Navigation Links
Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
Date:4/14/2008

Executive Leadership Changes Further Position Company to Meet Strategic

Growth Objectives

CINCINNATI, April 14 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the promotion of Simon S. Higginbotham to the role of President. Chris Bergen, who previously had served as President and Chief Operating Officer, will continue as Chief Operating Officer. In his new role as President, Mr. Higginbotham will provide global leadership for worldwide customer and business expansion to include strategic customer relations and new market opportunities. Assuming the position of Vice President and Chief Marketing Officer held previously by Mr. Higginbotham is Alan J. Boyce, who brings extensive senior-level sales and marketing experience in the biopharmaceutical industry to Kendle. Mr. Boyce was Vice President, Global Clinical Development -- Europe and Africa for Kendle from 2003 to 2007. In his new role with Kendle he will provide global leadership for the company's new business development and marketing initiatives. Combined, these executive leadership changes further realign Kendle with its long-term growth strategy and position the company to deliver improved value to its customers and shareholders.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"As we embark on the next stage of our corporate growth, it is imperative we have the dedicated leadership strength in place to support our needs as a larger global organization," said Candace Kendle, PharmD, Chairman and Chief Executive Officer. "Simon Higginbotham is a proven leader within Kendle and has been a key member of our executive team since joining the company in 2004. He has demonstrated outstanding leadership and customer focus and has delivered exceptional results across his tenure with our company, guiding our global sales organization to record results. We are extremely pleased to announce his promotion to this new leadership role and look forward to his continued contributions to our organization."

Dr. Kendle continued, "We also are pleased to announce the return of Alan Boyce to Kendle. Alan has an in-depth understanding of the Kendle organization and our customers and we look forward to his leadership as we continue to focus on delivering best-in-class clinical development solutions."

Both Mr. Higginbotham and Mr. Boyce bring extensive industry expertise to their respective leadership roles. Mr. Higginbotham has more than 20 years' experience in senior leadership positions in the CRO and biopharmaceutical industries. He currently serves on the Board of Directors of the Association of Clinical Research Organizations (ACRO). Mr. Boyce most recently was Chief Operating Officer for Synexus, a multinational clinical study recruitment and management firm. His experience also includes 18 years in senior sales and marketing roles with Procter & Gamble Pharmaceuticals.

About Kendle

Kendle (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services we offer experience spanning 90 countries, along with industry- leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges. Kendle was named "Top CRO to Work With" in the Thomson CenterWatch 2007 survey of U.S. investigative sites and "Best CRO" for 2007 and 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202, United States or from the company's Web site at http://www.kendle.com .


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
2. Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
3. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
4. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
5. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
6. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
7. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
8. MassMutual Promotes Debra Palermino to Senior Vice President of Human Resources
9. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
10. Vitasoy Promotes the Soy Breast Health Connection
11. AvMed Promotes Kirk Cianciolo to Senior Vice President and Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 to 2015, ... for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To combat the ... proposes a tax on prescription opioids to fund drug rehabilitation and prevention services.(3) ...
(Date:3/26/2017)... ... March 26, 2017 , ... ... receive the RealSelf 100 Award, a prestigious award honoring the top influencers on ... to find and connect with doctors and clinics. , In 2016, more than ...
(Date:3/24/2017)... ... March 24, 2017 , ... Clean Earth, Inc., ... and hazardous and non-hazardous materials announced today the acquisition of privately owned ... add four additional processing facilities and a vast array of additional technologies, services, ...
(Date:3/24/2017)... ... March 24, 2017 , ... Infectious disease affects billions of ... United States, it’s a threat that is constantly changing and evolving. Mediaplanet's “Fighting ... offers strategies for the healthcare community to help decrease the number of completely ...
(Date:3/24/2017)... ... March 24, 2017 , ... According to a new study by NCPA Senior ... not obey the rules Congress has directed the CBO to follow. The CBO itself ... would restore. Yet, it estimates a reduction in employer-based coverage due to the GOP ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Impax Laboratories, Inc. ... appointed Paul M. Bisaro as Impax,s President ... Company,s Board, effective March 27, 2017. Mr. Bisaro will ... as Interim President and Chief Executive Officer since December ... generic and branded pharmaceutical experience, Mr. Bisaro, 56, is ...
(Date:3/27/2017)... 2017 Invivotek, LLC, a Genesis Biotechnology Group ... pharmacology contract research organization (CRO), announced the completion ... expanded preclinical research facility in Hamilton, New ... renewable energy source to reduce costs and lessen the ... Genesis Solar Farm follows Invivotek,s recent expansion from a ...
(Date:3/24/2017)... , March 24, 2017  Zymo Research ... and Hamilton Robotics, Inc., who designs, manufactures ... ongoing collaboration that teams Zymo Research,s DNA ... and DNA extraction products with Hamilton,s high-throughput ... optimized methods for microbiomics and RNA isolation ...
Breaking Medicine Technology: